Therapeutic Education Strategy for Patients With Acute Heart Failure
- Conditions
- Heart Failure
- Interventions
- Behavioral: Therapeutic education
- Registration Number
- NCT03035123
- Lead Sponsor
- Resicard
- Brief Summary
The EduStra-HF study will examine the impact of an intensive therapeutic education on patients discharged from hospital after an episode of acute heart failure (HF).
Patients will be randomized into two groups: one will receive "usual care" monitoring and one will receive a specific educational monitoring programme for 1 year.
All patients will meet with a specialized therapeutic education nurse before discharge.
The effect of the intensive education on HF rehospitalization and quality of life will be examined.
- Detailed Description
The prevalence of HF in France is increasing. According to a report from the Haute Autorité de Santé (HAS) - the French Health Authority - published in June 2015 concerning discharge of patients hospitalized for HF, 2.3% of the French adult population is affected. Despite improvements in treatment and HF-specific care, the rehospitalization rate for HF remains substantial, and HF management is a major public health issue.
Chronic HF leads to psychological and physiological issues in patients. Furthermore, this disease affects patient quality of life and activities of daily living.
The HAS also reported that even if iterative hospitalizations are the consequence of complicated and multifactorial situations, some could be prevented by improved patient care.
The aim of the EduStra-HF study is to examine the effect of an intensive therapeutic education on patients discharged from hospital after an episode of acute HF. It will study whether this intervention reduces the rate of rehospitalization and increases quality of life in this population.
To achieve this goal, a multicentre, randomized, two parallel arm study will be conducted. Patients will be included in several cardiology centres in Paris (Ile-de-France) over 2 years and 3 months.
Included patients, chosen from patients admitted for acute HF in the participating hospitals, will be randomized into two groups, which will determine the monitoring they receive after discharge. For each patient, monitoring will last for 1 year from the day they return home.
The first group of patients will be randomized to receive "usual care" monitoring and will not be given specific therapeutic education after discharge.
The second group (intervention arm) will receive a specific educational monitoring programme from nurses via telephone calls and home visits, for 1 year. Monitoring will began early after discharge. Annual medical monitoring and visits to the cardiologist will also be planned.
All patients, regardless of attribution arm, will meet a nurse trained in therapeutic education during their stay in hospital. Moreover, validated and HF-related self-assessed questionnaires will be analyzed to assess quality of life and impact of HF on patient activities of daily living.
In the interventional arm, patients will receive monitoring documents, such as a HF information booklet and a personal monitoring agenda.
The EduStra-HF study will provide a specific analysis of a multisupport therapeutic education (including medical monitoring). Data on all HF drug treatments, including the more recent ones (e.g. Entresto), blood tests results, and cardiologic data will be recorded.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 318
- Adult patient with acute HF
- Affiliated to the French Social Security system
- Accepting the principle of telephone monitoring
- Accepting home visits from a study nurse
- Possession of a mobile phone
Psychosocial:
- Refusal to accept the study design
- Patient under guardianship
- Monitoring obstacle: language, cognitive deficiency, itinerant lifestyle, regular travel, institutionalization
- Inability to sign the consent form or to complete questionnaires
Medical:
- Active cancer
- Severe psychiatric or neurological disorder
- Complicated acute myocardial infarction
- Significant valvular diseases requiring surgery
- Hypertrophic obstructive cardiomyopathy
- Planned heart transplant
- Cardiac surgery in the previous 3 months
- Enrollment in another clinical trial
- Medical or surgical procedure which might interfere with monitoring
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Interventional Therapeutic education Before discharge, patients will attend an appointment with a nurse trained in therapeutic education, in which the nurse will evaluate the overall knowledge and the skills of the patient about HF. The nurse will then define specific educational objectives with the patient, based on the patient's medical history, state of disease, comorbidities, alarm signs, fears and knowledge. Each patient will receive six telephone calls and two home-visits during the 1 year of follow-up. Each contact between the nurse and the patient will be dedicated to HF education. The patient will also receive regular short text messages containing health advice and appointment reminders. To help the patient regain his/her autonomy, intervals between education sessions will be progressively longer.
- Primary Outcome Measures
Name Time Method Number of rehospitalizations for acute heart failure (HF) in both groups of patients 1 year
- Secondary Outcome Measures
Name Time Method B-type natriuretic peptide (BNP) or NT pro-BNP levels During 1 year of follow-up Cardiovascular and all-cause mortality rate 1 year of follow-up Quality of life linked to Heart Failure 1 year Assessed by validated questionnaire KCCQ-15
Hospitalization rate for cardiovascular diseases except HF 1 year of follow-up Global quality of life 1 year Assessed by validated questionnaire SF-12
Patients knowledge about the illness 1 year Nurses will evaluate during each telephone call and home visit patients knowledge and skills about the following items : illness, treatments, diet, physical activity, medical follow-up. This data will be recorded in a specific table and classified into "acquired / partially acquired / not acquired" items.
Length of stay for HF and all-cause hospitalizations 1 year of follow-up
Trial Locations
- Locations (6)
Clinique du Mont Louis
🇫🇷Paris, France
Hopital AP-HP Saint-Antoine
🇫🇷Paris, France
Centre Hospitalier André Mignot
🇫🇷Versailles, France
Clinique Ambroise Paré
🇫🇷Neuilly-sur-Seine, France
Institut Mutualiste Montsouris
🇫🇷Paris, France
Centre Cardiologique du Nord
🇫🇷Saint Denis, France